Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
NVO
PFE
Add up to 3 more stocks
NVO
Novo Nordisk A/S
-2.12%
$42.53-0.92Delayed quote: Sep 15, 2026, 4:00 PM EDT
Market Cap
$188.86B
52W Range
$35.12 - $64.16
PFE
Pfizer Inc.
-0.60%
$27.55-0.16Delayed quote: Sep 15, 2026, 4:02 PM EDT
Market Cap
$157.02B
52W Range
$23.58 - $29.21
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | 10.48 | 36.40 |
| Forward P/E | N/A | 9.26 |
| P/B Ratio | 5.60 | 1.84 |
| P/S Ratio | 3.70 | 2.47 |
| P/FCF Ratio | 25.35 | 14.29 |
| EV/EBITDA | 7.76 | 10.11 |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 80.6% | 71.3% |
| Operating Margin | 43.1% | 25.1% |
| Net Margin | 35.3% | 6.8% |
| ROE | 53.5% | 5.1% |
| ROA | 19.9% | 2.2% |
| ROIC | 30.2% | 9.3% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 0.87 | 1.27 |
| Quick Ratio | 0.66 | 0.96 |
| Debt/Equity | 0.63 | 0.74 |
| Interest Coverage | 30.34 | 5.78 |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | 4.2% | 6.2% |
| Payout Ratio | 44.3% | 227.3% |
| Yrs of Dividend Growth | 6 | 16 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.